Dechant Robert Thomas's Form 4/A amendment
AmendedIBEX Ltd (IBEX) · filed Nov 13, 2025
- Accession no.
- 0001298255-25-000013
- Filed
- Nov 13, 2025
- Trade date
- Sep 16, 2025
- Filing delay
- 58 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Sep 17, 2025
This filing lists 1 derivative transaction. It carries over 2 transactions from the original filing that it did not restate. Open-market sales total $1.75M. It was filed 58 days after the trade.
This amendment restates part of 0001298255-25-000007 (filed Sep 17, 2025). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dechant Robert ThomasCIK 0001298255 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | Common Shares | MOption exerciseDisposed | −45,027 | $0.00 | $0 | 0 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001298255-25-000007 (filed Sep 17, 2025).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | Common Shares | MOption exerciseAcquired | +45,027 | $19.00 | +$855,513 | 237,026 | Direct | |
| Sep 16, 2025 | Common Shares | SSaleDisposed | −45,027 | $38.89 | −$1,751,100.03 | 191,999 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The acquisition and sale of the common shares underlying these options was previously reported on Form 4 on September 17, 2025. The exercise of the options was inadvertently not included in that Form 4 filing, so is now reported in this Amendment.
- F2
The shares subject to this option are fully vested and exercisable.